Cohort Study: Survival outcomes associated with cytoreductive nephrectomy in patients with metastatic clear cell renal cell carcinoma.
17 May, 2022 | 10:41h | UTC
Commentary on Twitter
In this cohort study, instrumental variable analysis did not find a survival advantage associated with cytoreductive nephrectomy for patients with metastatic clear cell renal cell carcinoma. https://t.co/iljbmtZW4f
— JAMA Network Open (@JAMANetworkOpen) May 16, 2022